Figure 3.
Use of oral anticoagulation (warfarin or dabigatran) according to CHA2DS2‐VASc score and provider specialty. This figure displays the distribution of oral anticoagulation use by provider specialty. CHA2DS2‐VASc indicates congestive heart failure, hypertension, age ≥75 years, diabetes mellitus, prior stroke or TIA or thromboembolism, vascular disease, age 65 to 74 years, sex category; AF, atrial fibrillation; EP, electrophysiology; TIA, transient ischemic attack.